Ronald A Cohen1,2, Joseph M Gullett1,2, Eric C Porges1,2, Adam J Woods1,2, Damon G Lamb3,4, Vaughn E Bryant1,2, Mikayla McAdams5, Karen Tashima5, Robert Cook6, Kendall Bryant7, Mollie Monnig8, Christopher W Kahler8, Peter M Monti8. 1. Center for Cognitive Aging and Memory , University of Florida, Gainesville, Florida. 2. Department of Clinical and Health Psychology , University of Florida, Gainesville, Florida. 3. Department of Psychiatry , University of Florida, Gainesville, Florida. 4. Malcom Randall VA Medical Center , Gainesville, Florida. 5. Department of Infectious Medicine , The Miriam Hospital, Alpert College of Medicine, Brown University, Providence, Rhode Island. 6. Department of Epidemiology , University of Florida, Gainesville, Florida. 7. National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland. 8. Department of Behavioral Sciences , School of Public Health, Brown University, Providence, Rhode Island.
Abstract
BACKGROUND: There is growing concern about the health impact of heavy alcohol use in people infected with human immunodeficiency virus (HIV+). Mixed findings of past studies regarding the cognitive impact of alcohol use in HIV+ adults have been mixed, with inconsistent evidence that alcohol consumption exacerbates HIV-associated brain dysfunction. This study examined contributions of current heavy drinking, lifetime alcohol use disorder (AUD), and age to cognitive deficits in HIV+ adults, and relative to other HIV-associated clinical factors. METHODS: Cognitive performance of HIV+ adults (n = 104) was assessed, and comparisons were made between heavy current to nonheavy drinkers (NIAAA criteria), lifetime AUD versus no-AUD, and older (>50 years) versus younger participants. Hierarchical regression analyses were conducted to examine the association between cognitive performance and current heavy drinking, lifetime AUD, and older age, while also correcting for HIV clinical factors and history of other substance use. RESULTS: Individuals reporting current heavy drinking and meeting criteria for lifetime AUD demonstrated the greatest degree of deficits across multiple cognitive domains. Deficits were greatest among HIV+ adults with lifetime AUD, and older age was also associated with weaker cognitive performance. Lifetime AUD and older age independently exhibited stronger associations with cognitive performance than HIV clinical factors (e.g., viral load, current CD4, and nadir CD4) or past opiate and cocaine use. CONCLUSIONS: Current heavy drinking and lifetime AUD adversely affect cognitive function in HIV+ adults. Greatest deficits existed when there was a history of AUD and continued current heavy drinking, indicating that past AUD continues to have an adverse impact and should not be ignored. That alcohol use was more strongly associated with cognitive performance than HIV clinical factors underscore clinical importance of targeting reduction in heavy alcohol consumption in HIV+ adults.
BACKGROUND: There is growing concern about the health impact of heavy alcohol use in peopleinfected with human immunodeficiency virus (HIV+). Mixed findings of past studies regarding the cognitive impact of alcohol use in HIV+ adults have been mixed, with inconsistent evidence that alcohol consumption exacerbates HIV-associated brain dysfunction. This study examined contributions of current heavy drinking, lifetime alcohol use disorder (AUD), and age to cognitive deficits in HIV+ adults, and relative to other HIV-associated clinical factors. METHODS: Cognitive performance of HIV+ adults (n = 104) was assessed, and comparisons were made between heavy current to nonheavy drinkers (NIAAA criteria), lifetime AUD versus no-AUD, and older (>50 years) versus younger participants. Hierarchical regression analyses were conducted to examine the association between cognitive performance and current heavy drinking, lifetime AUD, and older age, while also correcting for HIV clinical factors and history of other substance use. RESULTS: Individuals reporting current heavy drinking and meeting criteria for lifetime AUD demonstrated the greatest degree of deficits across multiple cognitive domains. Deficits were greatest among HIV+ adults with lifetime AUD, and older age was also associated with weaker cognitive performance. Lifetime AUD and older age independently exhibited stronger associations with cognitive performance than HIV clinical factors (e.g., viral load, current CD4, and nadir CD4) or past opiate and cocaine use. CONCLUSIONS: Current heavy drinking and lifetime AUD adversely affect cognitive function in HIV+ adults. Greatest deficits existed when there was a history of AUD and continued current heavy drinking, indicating that past AUD continues to have an adverse impact and should not be ignored. That alcohol use was more strongly associated with cognitive performance than HIV clinical factors underscore clinical importance of targeting reduction in heavy alcohol consumption in HIV+ adults.
Authors: P Todd Korthuis; David A Fiellin; Kathleen A McGinnis; Melissa Skanderson; Amy C Justice; Adam J Gordon; Donna Almario Doebler; Steven M Asch; Lynn E Fiellin; Kendall Bryant; Cynthia L Gibert; Stephen Crystal; Matthew Bidwell Goetz; David Rimland; Maria C Rodriguez-Barradas; Kevin L Kraemer Journal: J Acquir Immune Defic Syndr Date: 2012-10-01 Impact factor: 3.731
Authors: María J Marquine; Jessica L Montoya; Anya Umlauf; Pariya L Fazeli; Ben Gouaux; Robert K Heaton; Ronald J Ellis; Scott L Letendre; Igor Grant; David J Moore Journal: Clin Infect Dis Date: 2016-05-19 Impact factor: 9.079
Authors: Joseph Conigliaro; Tamra Madenwald; Kendall Bryant; Scott Braithwaite; Adam Gordon; Shawn L Fultz; Stephen Maisto; Jeffrey Samet; Kevin Kraemer; Robert Cook; Nancy Day; Diedra Roach; Susan Richey; Amy Justice Journal: Alcohol Clin Exp Res Date: 2004-02 Impact factor: 3.455
Authors: Amy C Justice; K A McGinnis; M Skanderson; C C Chang; C L Gibert; M B Goetz; D Rimland; M C Rodriguez-Barradas; K K Oursler; S T Brown; R S Braithwaite; M May; K E Covinsky; M S Roberts; S L Fultz; K J Bryant Journal: HIV Med Date: 2009-09-14 Impact factor: 3.180
Authors: Talia R Seider; Assawin Gongvatana; Adam J Woods; Huaihou Chen; Eric C Porges; Tiffany Cummings; Stephen Correia; Karen Tashima; Ronald A Cohen Journal: J Neurovirol Date: 2015-10-07 Impact factor: 2.643
Authors: M Concha; N M Graham; A Muñoz; D Vlahov; W Royal; M Updike; T Nance-Sproson; O A Selnes; J C McArthur Journal: Am J Epidemiol Date: 1992-12-01 Impact factor: 4.897
Authors: Talia R Seider; Xi Luo; Assawin Gongvatana; Kathryn N Devlin; Suzanne M de la Monte; Jesse D Chasman; Peisi Yan; Karen T Tashima; Bradford Navia; Ronald A Cohen Journal: J Clin Exp Neuropsychol Date: 2014-03-19 Impact factor: 2.475
Authors: Vaughn E Bryant; Robert A Fieo; Andrew J Fiore; Veronica L Richards; Eric C Porges; Renessa Williams; Huiyin Lu; Zhi Zhou; Robert L Cook Journal: AIDS Behav Date: 2021-09-22
Authors: Mollie A Monnig; Joseph M Gullett; Eric C Porges; Adam J Woods; Peter M Monti; Karen Tashima; Neda Jahanshad; Paul Thompson; Talia Nir; Ronald A Cohen Journal: J Neurovirol Date: 2021-11-08 Impact factor: 3.739
Authors: Vaughn E Bryant; Mark K Britton; Joseph M Gullett; Eric C Porges; Adam J Woods; Robert L Cook; John Williamson; Nicole Ennis; Kendall J Bryant; Carolyn Bradley; Ronald A Cohen Journal: AIDS Behav Date: 2021-02-07
Authors: Nicholas Rhoades; Norma Mendoza; Allen Jankeel; Suhas Sureshchandra; Alexander D Alvarez; Brianna Doratt; Omeid Heidari; Rod Hagan; Brandon Brown; Steven Scheibel; Theodore Marbley; Jeff Taylor; Ilhem Messaoudi Journal: Front Immunol Date: 2019-03-12 Impact factor: 7.561
Authors: Htein Linn Aung; Maral Aghvinian; Hetta Gouse; Reuben N Robbins; Bruce J Brew; Limin Mao; Lucette A Cysique Journal: AIDS Behav Date: 2020-10-06